A. E. van der Bijl

The effect of anti-tumour necrosis factor α treatment on the antibody response to influenza vaccination

L. B. S. Gelinck, A. E. van der Bijl, W.E.P. Beyer et al. · Annals of the Rheumatic Diseases · 2007 · 174 citations

Infliximab and methotrexate as induction therapy in patients with early rheumatoid arthritis

A. E. van der Bijl, Y P M Goekoop-Ruiterman, Jeska K de Vries‐Bouwstra et al. · Arthritis & Rheumatism · 2007 · 122 citations

An open-label pilot study of the effectiveness of adalimumab in patients with rheumatoid arthritis and previous infliximab treatment: relationship to reasons for failure and anti-infliximab antibody status

A. E. van der Bijl, Ferdinand C. Breedveld, Christian Antoni et al. · Clinical Rheumatology · 2008 · 83 citations · Full text

Sustained Beneficial Effects of a Protocolized Treat‐to‐Target Strategy in Very Early Rheumatoid Arthritis: Three‐Year Results of the Dutch Rheumatoid Arthritis Monitoring Remission Induction Cohort

M. Vermeer, H. H. Kuper, Hein J. Bernelot Moens et al. · Arthritis Care & Research · 2013 · 77 citations

Synergistic immunosuppressive effect of anti-TNF combined with methotrexate on antibody responses to the 23 valent pneumococcal polysaccharide vaccine

L. B. S. Gelinck, A. E. van der Bijl, Leo G. Visser et al. · Vaccine · 2008 · 69 citations

Vaccination, Mucosal Vaccination, Medicine +9